SENORES PHARMACEUTICALS L (SENORES) — Net Asset Quality Index
SENORES PHARMACEUTICALS L (SENORES) has a Net Asset Quality Index of 60.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs16.04 Billion minus total liabilities of Rs6.39 Billion yields net assets of Rs9.65 Billion. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see SENORES market cap overview.
Quality Index
Net Assets
Total Assets
Total Liabilities
SENORES PHARMACEUTICALS L Net Asset Quality Index Over Time (2022–2026)
This chart shows how SENORES PHARMACEUTICALS L's Net Asset Quality Index has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the index stands at 60.1%, representing net assets of Rs9.65 Billion against total assets of Rs16.04 Billion INR. See SENORES PHARMACEUTICALS L book value and equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for SENORES PHARMACEUTICALS L (2022–2026)
The table below presents the year-by-year Net Asset Quality Index for SENORES PHARMACEUTICALS L from 2022 to 2026, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Also explore SENORES year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 60.1% | Rs9.65 Billion | Rs16.04 Billion | Rs6.39 Billion | ▼ -5.1 pp |
| 2025 | 65.2% | Rs94.96 Million | Rs145.66 Million | Rs50.70 Million | ▲ +27.9 pp |
| 2024 | 37.3% | Rs2.32 Billion | Rs6.22 Billion | Rs3.90 Billion | ▲ +2.5 pp |
| 2023 | 34.7% | Rs454.99 Million | Rs1.31 Billion | Rs855.54 Million | ▼ -27.1 pp |
| 2022 | 61.9% | Rs365.90 Million | Rs591.52 Million | Rs225.62 Million | — |